Duncan Williams Asset Management, LLC Abbott Laboratories Transaction History
Duncan Williams Asset Management, LLC
- $254 Billion
- Q4 2024
A detailed history of Duncan Williams Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Duncan Williams Asset Management, LLC holds 4,660 shares of ABT stock, worth $596,153. This represents 0.21% of its overall portfolio holdings.
Number of Shares
4,660
Previous 3,519
32.42%
Holding current value
$596,153
Previous $401 Million
31.38%
% of portfolio
0.21%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,224Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$21.5 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.81 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.41 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.82 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $224B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...